Cite
HARVARD Citation
Cosgrove, S. et al. (n.d.). A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis. Veterinary dermatology. 24 (6), pp. 587-e142. [Online].